Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 20.04% vs -10.38% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 246.76% vs -26.53% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is -19.83% vs -20.91% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 185.71% vs 133.33% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Compare Quarterly Results Of Laboratorios Farmaceúticos Rovi SA With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is 25.70% vs -30.17% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 20.04% vs -10.38% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 696.81% vs -77.99% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 246.76% vs -26.53% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is 54.14% vs -71.32% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -19.83% vs -20.91% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is 150.00% vs 0.00% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 185.71% vs 133.33% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025






